Besides the dysregulated acetyl/SUMO switch of FXR [220], the glucose-sensing O-GlcNAcylation pathway contributes to NAFLD in obesity [221]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.